Studies across 14 nations show 25% to 30% rate of long COVID Among the 25% of participants in 1 study who said they experienced long-COVID symptoms, 13% reported sleep disorders. CIDRAP

A new study in BMJ Global Health across 13 middle- and high-income countries reveals that 25% of patients reported symptoms of long COVID after symptomatic COVID-19, and long COVID is significantly more prevalent in participants from less wealthy nations and in patients of Arab or North African ethnicity.

...

CDC considers narrowing its Covid-19 vaccine recommendations | CNN The US Centers and Disease Control and Prevention is considering recommending annual Covid-19 shots to those who are older or who have compromised immune function, rather than the current blanket recommendation for everyone 6 months of age and older. Brenda Goodman CNN

...

US CDC advisers begin review of vaccine guidelines after months-long delay

Reports: Paxlovid doesn't relieve adult long-COVID symptoms, prevent condition in youth Tomorrow, pharmaceuticals will no longer be exempt from the Trump administration's 25% tariff on goods produced in Canada. CIDRAP

A pair of new studies finds no significant benefit of the antiviral drug nirmatrelvir-ritonavir (Paxlovid) in alleviating the symptoms of adult long-COVID patients or in preventing the development of the condition in adolescents.

..